The combination of AR and two plasma biomarkers overall showed the most substantial improvement (AUC 0.65 to 0.81), compared to a single mRNA alone, in separation of clinically significant PCa out of all biomarkers examined. The gene discussed is AR; the disease is posterior cortical atrophy.